Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

NCT07457099 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Oral Squamous Cell Carcinoma
Locally Advanced Oropharyngeal Squamous Cell Carcinoma

Interventions

OTHER: Observation
RADIATION: Postoperative Radiotherapy
DRUG: PD-1 Inhibitor Maintenance Therapy

Sponsor

Zhujiang Hospital